VAXXAS
Live / Registered — Registered (as of 13 Jul 2021)
What this means for you
Registered since 13 Jul 2021. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79287747
- Registration number
- 6413534
- Mark type
- Stylized text
- Filed
- 20 Apr 2020
- Published for opposition
- 27 Apr 2021
- Registered
- 13 Jul 2021
- Attorney of record
- Gregory M. Krakau
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical, medicinal and therapeutic preparations for human and veterinary use for the treatment of infectious disease, allergies and oncology; vaccines; vaccine preparations; diagnostic preparations for medical or veterinary purposes; biological specimens, blood and plasma for human medical diagnostics and analysis; transdermal patches, bandages, poultices and medical dressings impregnated with vaccines; patches, bandages, poultices and medical dressings impregnated with vaccines; transdermal vaccine delivery system being patches for administering vaccines; pharmaceutical preparations for treating infectious disease, allergies and oncology contained in transdermal patches; skin patches for the transdermal delivery of pharmaceuticals for use in the treatment of infectious disease, allergies and oncology; transdermal patches for administering pharmaceuticals for use in the treatment of infectious disease, allergies and oncology and vaccines; intradermal patches for use in the medical treatment of infectious disease, allergies and oncology; intradermal vaccine delivery system being patches for administering vaccines; pharmaceutical preparations contained in intradermal patches for use in the medical treatment of infectious disease, allergies and oncology; skin patches for the intradermal delivery of pharmaceuticals for use in the treatment of infectious disease, allergies and oncology; intradermal patches for medical treatment for administering pharmaceuticals for use in the medical treatment of infectious disease, allergies and oncology and vaccines; micro-projection array patches for medical purposes impregnated with vaccines; structural parts and fittings for the aforesaid goods
- Class 010 — Medical apparatus: Surgical and medical apparatus and instruments, namely, vaccine and drug delivery microneedle array patches sold without medication; drug delivery devices and apparatus, namely, hermetically sealed applicators containing patches for applying vaccine sold without medication; drug delivery devices sold empty, namely, uncoated patches sold without medication; transdermal drug delivery devices and apparatus, namely, transdermal drug delivery patches sold without medication; intradermal drug delivery devices and apparatus, namely, intradermal drug delivery patches sold without medication; micro-projection drug delivery devices and apparatus, namely, drug delivery patches sold without medication; structural parts and fittings for the aforesaid goods
- Class 040 — Treatment of materials: Custom manufacturing services in the field of drug delivery patches; custom manufacture of medical devices, pharmaceuticals, diagnostic tests and testing kits; custom manufacture of micro-projection array patches; custom manufacture of drug delivery devices and apparatus; custom manufacture of transdermal drug delivery devices and apparatus; custom manufacture of intradermal drug delivery devices and apparatus; custom manufacture of micro-projection drug delivery devices and apparatus; advisory, consultancy and information services in relation to all of the aforesaid
- Class 042 — Scientific and technological services: Research, design and development services in the field of medical apparatus and instruments; medical research, design and development services in the field of drug delivery devices; research and development in the pharmaceutical and biotechnology fields; research and development of vaccines and medicines; drug discovery; vaccine screening, namely, safety testing of vaccines; scientific and technological research services related to immunopharmaceuticals and vaccines; biological research, clinical research in the field of immunology, vaccines, and medical research; conducting clinical trials for others; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; chemical and biochemical analysis services; medical and scientific research; pharmaceutical research services; laboratory testing services in the field of vaccines, pharmaceuticals; laboratory research in the fields of biotechnology, microbiology, molecular biology, nanotechnology analytical chemistry, biochemistry, medicinal chemistry and drug development; technology services, namely, design and development of computer hardware; scientific research, clinical research, development, advisory and consultancy services in relation to antibody production; research and development services in the field of antibodies; antibody generation services being research and development services; diagnostic and research services and screening in the field of infectious disease, allergies and oncology for medical research purposes; diagnostic testing services in the field of medical apparatus and instruments; medical research services; advisory services relating to diagnostic testing of products for quality control and safety purposes; research and development of products; advisory, consultancy and information services in relation to all of the aforesaid
- Class 044 — Medical, beauty and agricultural services: Medical, medical clinic, and healthcare services relating to vaccines; medical and veterinary consultancy; medical testing for diagnostic or treatment purposes; advisory, consultancy and information services in relation to all of the aforesaid
- Class 045 — Legal and security services: Legal services relating to the exploitation and licensing of intellectual property and technology; licensing of medical technology; legal services relating to the licensing of research and development of products; advisory, consultancy and information services in relation to all of the aforesaid
Owner
- Vaxxas Pty Ltd, Sydney, NSW, AU
- Vaxxas Pty Ltd, Sydney NSW, AU
- Vaxxas Pty Ltd, Sydney NSW, AU
Prosecution history
- 10 Oct 2023 — NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED
- 05 Sept 2023 — CORRECTION UNDER SECTION 7 - PROCESSED
- 30 Aug 2023 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 25 Mar 2022 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 25 Mar 2022 — CORRECTION UNDER SECTION 7 - PROCESSED
- 24 Mar 2022 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 28 Nov 2021 — FINAL DECISION TRANSACTION PROCESSED BY IB
- 09 Nov 2021 — FINAL DISPOSITION NOTICE SENT TO IB
- 09 Nov 2021 — FINAL DISPOSITION PROCESSED
- 31 Oct 2021 — TEAS SECTION 7 REQUEST RECEIVED
- 13 Oct 2021 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 13 Jul 2021 — REGISTERED-PRINCIPAL REGISTER
- 27 Apr 2021 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 27 Apr 2021 — PUBLISHED FOR OPPOSITION
- 24 Apr 2021 — NOTIFICATION PROCESSED BY IB